FREE CONSULTATION: 866-425-8902

scientist working on Xarelto trial

Manufacturers Admit Xarelto Failed In Phase III Trials

Bayer Inc and Johnson & Johnson have officially announced that their blood thinner Xarelto has failed a Phase III trial.

Not Superior To Aspirin

scientist working on Xarelto trialAccording to the two drug manufacturers, their drug did not perform well enough during testing to show that it was superior to aspirin in reducing the risk of stroke. The results were so poor that the study’s Independent Data Monitoring Committee recommended stopping the study early.

Patients involved in the study will switch to aspirin under the supervision of a doctor.

One of the other results noted in the trial that the patients being given Xarelto had an increased chance of having a “major bleeding event”. This fact will hardly surprise the thousands of plaintiffs who are currently waiting for their chance to present their Xarelto lawsuit in court.

Bleeding Events Just One Of The Risks Of Taking Xarelto

There are so many Xarelto lawsuits filed against the manufacturers of the blood thinner, nearly 20,000 in fact, that a decision was made to combine all complaints throughout the United States into an MDL, or Multidistrict Litigation.

In every single lawsuit, the plaintiff is alleging that the drug either caused them harm or caused someone they loved harm serious enough that they passed away. Since the drug was first put onto the market, doctors have reported the following side effects in their patients:

Excessive Bleeding That Can’t Be Stopped

While it is true that any patient who is on a blood thinner is at risk for excessive bleeding if they are wounded, older blood thinners like Warfarin can be reversed by administering an antidote. Xarelto has no antidote which means that doctors must use blood transfusions to try and stop the bleeding but cases where the injuries are extreme, a blood transfusion may not work in time.

Liver Dysfunction

microscope looking at blood samplesIn some patients, hepatitis and other liver dysfunctions can be a side effect of Xarelto. In 2014, the FDA released a warning about the potential for liver damage.

Brain Hemorrhage

Doctors have reported that their patients were diagnosed with a brain bleed after being prescribed Xarelto. If the bleed isn’t detected in time, they may suffer a stroke.

GI Bleeds

Bleeds have been discovered in the esophagus, large and small intestine, colon, rectum, and the anus. If not diagnosed quickly, the blood may pool and the pressure of this pooling will shut off the circulation to vital organs.

It is these side effects which plaintiffs allege caused them harm.

Why Is Xarelto Still On The Market?

Despite the fact that the FDA has issued several black box warnings, which are the strictest warnings that can be issued about a drug, they have not recalled the drug. Given the fact that the manufacturers make billions of dollars off of Xarelto, it’s unlikely that they will voluntarily pull the drug from the market.

How Can Filing A Xarelto Lawsuit Help?

When a patient is hurt because of a defective drug, they not only suffer physically but often financially. The purpose of a civil lawsuit is to give a plaintiff a chance to recover monetary compensation for their financial, physical, and even emotional losses.

If the patient died after being given Xarelto, their loved ones may be able to pursue justice on their behalf, through a wrongful death lawsuit. This can provide the family with compensation for the deceased’s lost income, the loss of inheritance, loss of consortium, and funeral and burial expenses.

The outcomes for each plaintiff will be different and based off of their actual losses. It is also likely that any amount will be obtained through a trial verdict rather than a settlement which is sometimes offered by the defendants.

Leave a Reply